Vanda Pharmaceuticals Inc.

VNDA

NASDAQ

Healthcare

Biotechnology

Washington, DC, US368 employeesvandapharma.com

$6.99

-0.09(-1.20%)

Mkt Cap $413M

$3.92

$9.56

52-Week Range

At a Glance

AI-generated

Vanda Pharmaceuticals Inc.

Revenue breakdown: Hetlioz (81.4%), PONVORY (18.6%).

8-K

Timothy Williams resigned as Senior Vice President, General Counsel and Secretary of Vanda Pharmaceuticals Inc., effective April 10, 2026, to pursue other endeavors.

$413M

Market Cap

$216M

Revenue

-$221M

Net Income

Employees368

Fundamentals

How The Business Makes Money

Revenue by Segment

Hetlioz81.4%($248M)

PONVORY18.6%($57M)

Activity

What Changed Recently

Management Change

Apr 1, 2026

. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b) Resig

Management Change

Feb 18, 2026

. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On February

Financial Results

Feb 10, 2026

of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 193

Regulation FD

Mar 9, 2026

shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) or otherwise subject to the l

Other Event

Feb 22, 2026

. Other Events. On February 20, 2026, Vanda Pharmaceuticals Inc. (“Vanda”) issued a press release announcing that the U.S. Food and Drug Administration has appr

Peer Companies

Company	Price	Change	Market Cap	P/E
CAPRCapricor Therapeutics, In...	$32.12	+6.62%	$1.5B	-14.0
ALLOAllogene Therapeutics, In...	$2.50	-2.54%	$608M	-2.8
TRDAEntrada Therapeutics, Inc...	$13.15	-2.45%	$503M	-3.3
AVIRAtea Pharmaceuticals, Inc...	$5.75	+1.86%	$459M	-2.7
VYGRVoyager Therapeutics, Inc...	$3.94	-1.13%	$235M	-1.9
ARCTArcturus Therapeutics Hol...	$8.00	+1.90%	$227M	-2.9
IMRXImmuneering Corporation	$5.45	+2.25%	$198M	-4.0
ACHVAchieve Life Sciences, In...	$3.23	+2.93%	$172M	-2.7

Analyst View

Company Profile

CIK0001347178

ISINUS9216591084

CUSIP921659108

Phone202 734 3400

Address2200 Pennsylvania Avenue NW, Washington, DC, 20037, US

SEC EDGAR